Rash and Neurological Symptoms

Journal of Emergency Medicine

Volumn 32, Issue 3, 2007, Pages 299-303

  McCormick, Jenny K ^a   Nadel, Eric S ^a,b,c   Brown, David F M ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DIFFERENTIAL DIAGNOSIS; EMERGENCY CARE; EMERGENCY WARD; FEMALE; HUMAN; LABORATORY DIAGNOSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RASH; RESIDENCY EDUCATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 33947506446     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2006.12.036     Document Type: Note

References (40)

1. Allford S.L., Hunt B.J., Rose P., and Machin S. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 120 (2003) 556-573
2. Bell W.R., Braine H.G., Ness P.M., and Kickler T.S. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325 (1991) 398-403
3. Chu Q.D., Medeiros L.J., Fisher A.E., Chaquette R.F., and Crowley J.P. Thrombotic thrombocytopenic purpura and HIV infection. South Med J 88 (1995) 82-86
4. Coppo P., Bussel A., Charrir S., et al. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome. Medicine (Baltimore) 82 (2003) 27-38
5. Rock G.A., Shumak K.H., Buskard N.A., et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325 (1991) 393-397
6. Ziman A., Mitri M., Klapper E., Pepkowitz S.H., and Goldfinger D. Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of the literature. Transfusion 45 (2005) 41-49
7. Sherer Y., Levy Y., Fabbrizzi F., and Shoenfeld Y. Treatment of hematologic disorders other than immune thrombocytopenic purpura with intravenous immunoglobulin (IVIg)-report of seven cases and review of the literature. Eur J Intern Med 11 (2000) 85-88
8. Crowther M.A., Heddle N., Hayward C.P.M., Warkentin T., and Kelton J.G. Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura. Ann Intern Med 125 (1996) 294-296
9. Rosove M.H., Ho W.G., and Goldfinger D. Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura. Ann Intern Med 96 (1982) 27-33
10. Harkness D., Byrnes J.J., Lian E.C.-Y., Williams W.D., and Hensley G.T. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA 246 (1981) 1931-1933
11. Willis M.S., and Bandarenko N. Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease?. Semin Thromb Hemost 31 (2005) 700-708
12. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc 24 (1924) 21-24
13. Amorosi E., and Ultmann J. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 45 (1966) 139
14. Moake J.L. Thrombotic microangiopathies. N Engl J Med 347 (2003) 589-600
15. Moake J.L., Rudy C.K., Troll J.H., et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307 (1982) 1432-1435
16. Moake J.L., Turner N.A., Stathopoulos N.A., Nolasco L.H., and Hellums J.D. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 78 (1986) 1456-1461
17. Furlan M., Robles R., and Lamie B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87 (1996) 4223-4234
18. Moake J.L. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Hematol 41 (2004) 4-14
19. Fujikawa K., Suzuki H., McMullen B., and Chung D. Purification of von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98 (2001) 1662-1666
20. Furlan M., Robles R., Galbusera M., et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339 (1998) 1578-1584
21. Furlan M., Robles R., Solenthaler M., and Lammle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 91 (1998) 2839-2846
22. Tsai H.-M., and Lian E.C.-Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339 (1998) 1585-1594
23. Karmali M.A., Petric M., Lim C., Fleming P.C., Arbus G.S., and Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151 (1985) 775-782
24. Cleary T.G. Cytotoxin-producing Escherichia coli and the hemolytic uremic syndrome. Pediatr Clin North Am 35 (1988) 485-501
25. Moake J.L. Haemolytic-uraemic syndrome: basic science. Lancet 343 (1994) 393-397
26. Karpman D., Papadopoulou D., Nilsson K., Sjogren A.-C., Mikaelsson C., and Lethagen S. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 97 (2001) 3100-3108
27. George J.N. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354 (2006) 1927-1935
28. Sanchez-Luceros A., Farias C.E., Amaral M.M., et al. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thromb Haemost 92 (2004) 1320-1326
29. George J.N. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 10 (2003) 339-344
30. Sloand E. Hematologic complications of HIV infection. AIDS Rev 7 (2005) 187-196
31. Begue R., Dennehy P.H., and Peter G. Hemolytic uremic syndrome associated with Streptococcus pneumoniae. N Engl J Med 325 (1991) 133-134
32. Kwaan H.C., and Gordon L.I. Thrombotic microangiopathy in the cancer patient. Acta Haematol 106 (2001) 52-56
33. Hauglustaine D., Van Damme B., Vanrenterghem Y., and Michielsen P. Recurrent hemolytic uremic syndrome during oral contraception. Clin Nephrol 15 (1981) 148-153
34. Ahmed F., Sumalnop V., Spain D.M., and Tobin M.S. Thrombohemolytic thrombocytopenic purpura during penicillamine therapy. Arch Intern Med 138 (1978) 1292-1293
35. Burke A.P., Mont E., Kolodgie F., and Virmani R. Thrombotic thrombocytopenic purpura causing rapid unexpected death: value of CD61 immunohistochemical staining in diagnosis. Cardiovasc Pathol 14 (2005) 150-155
36. Bennett C.L., Connors J.M., Carwile J.M., et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 342 (2000) 1773-1777
37. Bennett C.L., Weinberg P.D., Rozenberg-Ben-Dor K., Yarnold P.R., Kwaan H.C., and Green D. Thrombotic thrombocytopenic purpura associated with ticlopidine: a review of 60 cases. Ann Intern Med 128 (1998) 541-544
38. Clark W.F., Rock G.A., Buskard N., et al. Therapeutic plasma exchange: an update from the Canadian Apheresis Group. Ann Intern Med 131 (1999) 453-462
39. Ashley J.R., Otero H., and Aboulafia D.M. Bee envenomation: a rare cause of thrombotic thrombocytopenic purpura. South Med J 96 (2003) 588-591
40. Terrell D.R., Williams L.A., Vesely S.K., Lammle B., Hovinga J.A., and George J.N. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost 3 (2005) 1432-1436